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http://www.systematicreviewsjournal.com/content/2/1/8PROTOCOL Open AccessAssessment of causal link between psychological
factors and symptom exacerbation in
inflammatory bowel disease: a protocol for
systematic review of prospective cohort studies
Mariyana Schoultz*, Iain Atherton, Gill Hubbard and Angus JM WatsonAbstract
Background: Inflammatory bowel disease is an idiopathic chronic disease that affects around 28 million people
worldwide. Symptoms are distressing and have a detrimental effect on patients’ quality of life. A possible link
between exacerbation of symptoms and psychological factors has been suspected but not established. Previous
reviews concerned with this link had conceptual and methodological limitations. In this paper we set out a
protocol that lays the foundations for a systematic review that will address these shortcomings. The aim of this
review is to provide researchers and clinicians with clarity on the role of psychological factors in inflammatory
bowel disease symptom exacerbation.
Method/design: We will identify all original, published, peer reviewed studies relevant to the topic and published
in English from inception to November 2012. The databases MEDLINE, EMBASE, CINAHL and PsychINFO will be
systematically searched. The search terms will include: inflammatory bowel disease, Crohn’s disease, ulcerative
colitis, psychological stress, mental stress, life stress, family stress, hassles, social stress, coping, mood disorders,
anxiety and depression in sequential combinations.
Studies will be screened according to predetermined inclusion and exclusion criteria by two reviewers. We will
include clinical prospective cohort studies of all human participants aged 18 years or over with a diagnosis of
inflammatory bowel disease. All eligible papers will be independently and critically appraised using the Critical
Appraisal Skills Programme (CASP) tool by two reviewers. Two reviewers will independently extract and synthesise
data from the studies using a predefined data extraction sheet. Disagreements will be resolved by discussion
between reviewers and a third party will be consulted if agreement is not reached. Synthesised data will be
analysed using Bradford Hill criterion for causality. If data permits, meta-analysis will be performed.
Discussion: This study will provide the most comprehensive review and synthesis of current evidence around the
link between psychological factors and symptom exacerbation in inflammatory bowel disease. Results will inform
clinicians in appropriate intervention development for this patient group that would reduce symptom exacerbation
and therefore improve patients’ quality of life.
Keywords: Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Psychological factors, Symptom
exacerbation, Systematic review protocol* Correspondence: ms84@stir.ac.uk
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University of Stirling, Inverness, Scotland, UK
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Inflammatory bowel disease (IBD) is an idiopathic chronic
disease that affects around 250,000 patients in the United
Kingdom and around 28 million people worldwide [1,2].
IBD incidence is increasing with future prevalence likely
to be considerably greater than at present [3]. With no im-
minent prospects of cure, the need for effective symptom
management is becoming ever more pressing. Part of the
development of such interventions to relieve symptoms
requires a better understanding as to what actually trig-
gers those symptoms.
IBD encompasses various different conditions, with the
main two types being Crohn’s disease (CD) and ulcerative
colitis (UC). Both conditions are characterized by chronic
inflammation of the gastrointestinal tract. Clinically, they
are often considered together given their similar aetiology
and symptoms, but they differ in terms of which part of
the digestive tract they affect and in the nature of the
inflammation that they cause [4].
The symptoms experienced by this group of patients
are often distressing. They include abdominal pain, bloody
diarrhoea, nutritional failure and weight loss. However,
they are not limited to the gastrointestinal tract only and
can also cause ocular, musculoskeletal and skin patholo-
gies [5]. All can occur intermittently, with periods of
remission and exacerbation being experienced throughout
the patient’s life. The impact of these IBD symptoms can
adversely affect patients’ quality of life, affecting them psy-
chologically, socially, educationally and vocationally [6].
Evidence suggests that a high proportion of IBD patients
suffer from anxiety and depression, a percentage that is
more than double when compared to healthy population
[7]. This observed high anxiety and depression comorbid-
ity in IBD patients have led many researchers and clini-
cians to believe that there could be a causal relationship
between anxiety, depression (psychological factors in gen-
eral) and IBD symptoms, even more so when other chro-
nic diseases have established such links [8-10].
The idea about possible causality between psycholo-
gical factors and IBD symptoms is not new and firstly
emerged in the 1930s [11]. Since, there have been a num-
ber of reviews examining the evidence concerned with
the issue, and to date, their conclusions remain somewhat
contradictory [12-20]. Some have concluded that psycho-
logical factors contribute to exacerbations of symptoms
[15,17] while others have refuted it [14]. More recent re-
views, however, are leaning towards psychological factors
having an impact on IBD symptomology, but they remain
controversial and unclear [12,18-20].
This lack of clarity has brought a lot of confusion [21],
particularly when empirical evidence from animal stud-
ies is suggesting potentially causal mechanisms between
depression and inflammation [22,23]; and around 74% of
IBD patients seem to believe that psychological factorssuch as anxiety and depression contribute towards symp-
tom exacerbation [24].
This potentially causal mechanism between depression
and inflammation and the patient’s belief are noteworthy
influences when considering why the previous reviews
have arrived at contradictory findings. Methodological
weaknesses of the reviews themselves and weaknesses
of the studies on which they were based on are just
some of the possibilities explored by previous researchers
[25] as well as the conceptual limitations [16]. Both me-
thodological and conceptual limitations have stemmed
from the complexity of the disease, the difficulty in de-
fining psychological factors and their relationship with
symptom exacerbation. All of them need a careful con-
sideration when planning and determining the objectives
of a systematic review such as this one. A summary of
those identified potential limitations and recommenda-
tions are as follows:
1. The aggregation problem: some studies have
assumed the psychological-physical symptom
relationship to be the same for both UC and CD
[19,26,27];
2. Disease activity measures: different measures of
disease activity have varying levels of validity and
reliability. Contrasting findings may thus have
resulted depending on which tools were used [12,25];
3. Definition and measurement of psychological factors:
psychological factors are complex and encompass a
range of aspects and degrees of severity which could
each have different implications for disease
symptoms [17,25]. Similarly, utilising different tools
may lead to apparently contradictory findings [28];
4. Direction of causality: studies available to previous
systematic reviews have been unable to disentangle
whether stress causes symptoms or symptoms cause
stress, which more recent studies may have
addressed [17];
5. A moderation affect: psychological factors may be an
important factor for some personality types but less
so, or even not at all, for others [29]. Study
participants will have had different degrees of coping
skills with implications for the relationship between
psychological factors and disease activity. Those with
more effective ability to cope will potentially have
been less at risk of experiencing exacerbation of
symptoms [30,31].
Previous reviews
Systematic reviews provide robust and comprehensive
overviews of research findings within a specified topic area.
The aim of systematic reviews, unlike the non-systematic
approach of literature reviews and overviews, is to minim-
ise bias and offer reproducibility while using scientific and
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following transparent, systematic and robust procedures.
A number of previous reviews concerned with the role
of psychological factors and symptom exacerbation have
not followed a systematic approach [12,18]. These papers
were limited because only a single database was searched
and potentially important studies were missed. This li-
mitation might have resulted in the authors arriving at
misleading conclusions. Others did not provide a clear de-
scription of their methods [19,20], denying other research-
ers the opportunity to make judgments on their scientific
robustness [12,13,18].
Some reviews have treated IBD as a single entity [17]
while others analysed specifically UC patients [14] or
CD patients [15]. We highlighted earlier that IBD con-
sists of two different diseases. For most purposes they
are so similar that aggregating them together makes sense
[33]. However, it has been shown that patients with clinic-
ally similar disease might vary physiologically, at a mo-
lecular level [34,35], which makes its just possible that the
relationship between the psychological and physical symp-
tomology differs in individual patients. If this were the
case, then the constituent conditions should be disaggre-
gated for analytical purposes where psychological influ-
ences are being considered. The subtlety different focuses
may be a reason why the papers arrived at differing con-
clusions and why a review is required that distinguishes
between UC and CD.
Justification
Among the criticism about methodological and concep-
tual limitations, there are recommendations of previous
robust reviews that should not be ignored [14-17]. How-
ever, the most recent of these is now more than a decade
old, a period of time during which many more studies are
likely to have been carried out. Hence, that makes a clear
justification for this review to fill such a literature gap.
Causality
Simply reporting an association between psychological
factors and symptom exacerbation in IBD is not suf-
ficient to establish causality. To prevent misleadingly
causal associations, the epidemiologist Bradford Hill pro-
posed a number of viewpoints later used as criteria that
should be considered before declaring a causal relation-
ship truly exists [36]. To date, no systematic review
examining causality between psychological factors and
symptom exacerbation in IBD has explicitly applied the
Bradford Hill criteria to assess the evidence supporting a
potentially causal association between the two.
Hence, in this paper we set out a protocol that lays the
foundations for such a systematic review that will apply
the Bradford Hill criteria for causality while bypassing the
limitations noted from previous studies. The outcome ofthis review will provide clinicians with a clear foundation
on which they might be able to develop therapies that
reduce the likelihood of symptom exacerbation and there-
fore improve patient quality of life.
Study aim and objectives
The aim of this study is to provide researchers and clini-
cians with clarity on the role of psychological factors in
IBD symptom exacerbation. In doing so, we will conduct
a systematic review that will synthesise available evi-
dence from prospective cohort studies that are reporting
on causal associations between psychological factors and
symptom exacerbation in IBD and on which we will
apply the Bradford Hill criteria for causality. Guided by
the recommendations from previous reviews outlined in
the background section, the specific objectives that will
help us attain our aim are:
1. To determine whether there is a causal relationship
between minor stressors and exacerbation of
symptoms in IBD patients and if any causality differ
between UC and CD patients;
2. Whether there is a causal relationship between life
events and exacerbation of symptoms in IBD patients
and if any causality differ between UC and CD
patients;
3. Whether there is a causal relationship between
personality type/trait and exacerbation of symptoms
in IBD patients and if any causality differ between
UC and CD patients.
To address the above specific objectives we will firstly
identify and then examine studies concerned with the
relationship between minor stressors and symptom re-
lapse, life events and symptom relapse, and personality
and symptom relapse in all IBD population. We will then
synthesise and evaluate data against Bradford Hill criteria
for causality and do meta-analysis if deemed appropriate.
Method/design
Study method
To ensure the methodology of this systematic review is
robust, we will follow the 27 checklist of PRISMA state-
ment and the guidance outlined by the Centre for Reviews
and Dissemination (CRD) [37,38]. Following this guidance
would ensure the methodological limitations of previ-
ous reviews outlined in the background section will be
avoided.
Criteria for considering studies for this review
Inclusion and exclusion criteria
To be included in the review, the papers will have to meet
the following set criteria relating to study type, population
Table 1 Screening check list for inclusion to review
Title
Yes No Unsure
Human
English language
Prospective cohort study
Reporting on psychological factors in IBD,
UC or CD and disease symptoms
Psychological variables (exposure) defined
Disease activity and symptom exacerbation
measures clearly defined
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language restrictions:
Study types We will only utilise prospective cohort stu-
dies that report on causal association between psycholo-
gical factors and symptom relapse in IBD patients. Thus,
data obtained from long-term cohort studies is of consid-
erably higher quality to those obtained from retrospective/
cross-sectional studies and retrospective cohort studies
[39]. Using prospective cohort study data for the system-
atic review will help observe the risk factors for symptom
relapse in IBD patients. Cohort studies involve observa-
tion of the individuals (over a period of time), and col-
lection of data at regular intervals, which reduces recall
error.
Cross-sectional studies are not able to ascertain the
direction of effect and thus will not be included in this
review. Previous reviews have acknowledged that using
studies with retrospective design to answer this question
could have contributed to the contradictory findings and
introduced recall bias [25]. Thus we will limit our review
to prospective cohort studies only.
Population of interest We will include studies with all
patients aged 18 years or older with diagnosis of Crohn’s
disease or ulcerative colitis. Studies using mixed sample
of both diagnosis will also be included. We will not use
any studies using mixed sample of children and adults.
While symptom presentation and therapeutic presenta-
tion could be similar between adults and children, signifi-
cant differences are noted between the two populations
[40].
Risk factors/exposure Psychological variable specifica-
tions.
We will include studies reporting on psychological fac-
tors where they are clearly defined and the measurement
tools used are clearly identified. As mentioned in the
background section, psychological factors can be many
and varied and often different studies will measure dif-
ferent psychological factors. For example, unspecified
‘stress’ will not be considered as valid psychological factor
since is too vague and difficult to be accurately measured,
but ‘daily stress’ or ‘perceived stress’ will be considered as
valid. A sample list of clearly identified psychological
factors is presented in the list below (the list is not
definitive).
A sample list of Psychological factors
Anxiety
Depression
Depressive mood
Major life events/bereavement/separation
Daily eventsSocial stress/support
Life stress
Work/employment stress
Family stress/support
Coping
Personality
Financial stress
Satisfaction/quality of life
Types of outcome measures reported by studies
Disease activity and symptom relapse/exacerbation
specifications
Studies reporting on disease activity and explicitly giv-
ing details on tools used to measure disease activity/
symptom relapse will be included in this review. Similar
to the psychological variable factors, disease activity and
symptom relapse/exacerbation have to be clearly defined
and measured. To be included in the review, studies will
have to give details on tools used for disease activity
measurement (for example, simple clinical colitis activity
index -SCCAI), and details on frequency of relapses,
exacerbations of symptoms and change of symptoms.
Language and geographical area limitations Only stu-
dies published in English will be included in the review.
Due to funding constraints, we are unable to translate
studies published in other languages at this stage. There
will be no geographical limitation for the included studies.
Search strategy for identification of studies
We will follow the guidance outlined by CRD [38] in the
search and selection of studies for the review to ensure
robustness. Two reviewers will independently attempt to
identify all studies relevant to the review while using a
pre-set screening checklist presented in Table 1. We will
only include those studies that meet all criteria. The
following four methods will be used to identify studies:
Electronic searches The database Medline will be sear-
ched via Ovid and PubMed, EMBASE via Ovid and
CINAHL and PsychInfo via Ebsco will be searched for
Table 2 Data extraction sheet
General information
Researcher’s name
Date of data extraction
Author
Article title
Citation
Type of publication (for example,
journal article, conference abstract)
Country of origin
Study characteristics Aim/objectives of the study
Study design
Study inclusion and exclusion criteria
Recruitment procedures used
(for example, details of randomisation,
blinding)
Unit of allocation (for example,
participant, GP practice, and so on)
Participant characteristic Age
Gender
Ethnicity
Socioeconomic status
Disease characteristics
Co-morbidities
Number of participants
Setting of the study
Outcome/results
Whether all outcomes were defined
and reported
Measurement tool or method used
Unit of measurement (if appropriate)
Length of follow-up, number and/or
times of follow-up
Type of analysis used in study
(for example, intention to treat,
per protocol
Conclusion as per authors
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ment of databases to November 2012. The CRD guidance
does not specify what constitutes a sufficient number of
databases searched for a review as that number can va-
ry from topic to topic [38]. Pragmatically, Medline and
EMBASE might reveal most of relevant studies, however,
the use of more specialised databases in addition might
bring studies that are relevant to the systematic review
and not included in the previous two [41].
We will use subject term services of the different data-
bases. The following search terms and their MeSH (medical
subject heading) equivalents will be used: inflammatory
bowel disease, Crohn’s disease, ulcerative colitis, psycho-
logical stress, mental stress, life stress, family stress, hassles,
social stress, coping, perceived stress, mood disorders, anx-
iety, depression, personality . These terms will be used in
various combinations and wildcards will be used to pick up
variant terminology. As per CRD guidance [38], a sample
search strategy for Medline is presented in the list below.
Search strategy for MEDLINE
1. Inflammatory Bowel Diseases/
2. Crohn’s Disease/
3. Colitis, Ulcerative/
4. Stress, Psychological/
5. mental stress.mp.
6. life stress.mp.
7. family stress.mp.
8. hassles.mp.
9. social stress.mp.
10. coping.mp.
11. perceived stress.mp.
12. mood disorders.mp. or Mood Disorders/
13. Anxiety/
14. Depression/
15. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12
or 13 or 14
16. 1 or 2 or 3
17. 15 and 16
Reference lists We will manually check the reference
list of all the studies included and identified by the above
search strategy to identify relevant studies that have not
been detected with the database searches. These studies
will be assessed against the inclusion criteria and
included if appropriate. We will also check the reference
list of any previous reviews on psychological factors in
inflammatory bowel disease for papers suitable for inclu-
sion in our review.
Citations databases We will check Citations Google
Scholar, Citations Web of Science and Citations Scopus
for papers that have cited the Searle and Bennett [17]
review to identify further papers that could be relevantand eligible for the review but that have not been identi-
fied using the search strategy identified above. We be-
lieve that this review is a key paper for the period up to
2001 and this paper would be referenced in more recent
studies.
Grey literature We will include unpublished material as
part of our search given that not all relevant material
will have been published. CRD recommends looking at
databases such as NTIS (National Technical Informa-
tion Service) and HMIC (Health Management Informa-
tion Consortium) for grey literature which may reveal
unpublished papers relevant to our review. We will also
Table 3 Grouping of studies data for analysis
Studies reporting on
following psychological
factors
Studies reporting on symptom
exacerbation in these patient
groups
Studies reporting on symptom
exacerbation in these patient
groups
Studies reporting on symptom
exacerbation in these patient
groups
Minor stressors UC patients CD patients Mixed CD and UC
Major life events UC patients CD patients Mixed CD and UC
Personality UC patients CD patients Mixed CD and UC
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relevant materials rough the British society of gastroen-
terologists (BSG) or the World Gastroenterology Orga-
nisation (WGO). An updated search will be conducted
immediately prior to data synthesis.Data collection and management
Screening and selection of studies All retrieved studies
identified by the search strategy will be downloaded onto
RefWorks and duplicates will be removed. Two revie-
wers will work independently. They will read title and
abstract of all papers sourced to determine suitability for
inclusion into the study based on the predetermined eli-
gibility criteria (see Table 1). Discrepancies and disagree-
ments regarding eligibility will be resolved by discussion.
All papers meeting the eligibility criteria will be included
for quality assessment in this systematic review. We willTable 4 Bradford Hill criteria for assessing causation in cohor
Criterion no. Bradford Hill Criteria [36]
1. Strength of the association The stronger the association betwe
risk factor and outcome, the more
the relationship is to be causal
2. Consistency of findings Have the same findings been obse
among different populations, in dif
study designs and different times?
3. Specificity of the association When a single assumed cause prod
specific effect outcome
4. Temporal sequence of association Exposure must precede outcome
5. Biological gradient Changes in disease rates should be
with changes in exposure (dose–re
6. Biological plausibility Presence of a potential biological m
of causality
7. Coherence Does the relationship agree with th
knowledge of the natural history/b
the disease?
8. Experiment Does the removal of the exposure
frequency of the outcome?record reasons for exclusion of any papers excluded in
quality assessment stage.
Authors will be contacted in order to clarify missing data
or unclear information.
Data extraction and management The two reviewers
will independently extract data using a predesigned data
extraction form (see Table 2). The extracted data will be
grouped in general information, study characteristics,
participant characteristics, setting and intervention and
outcome/result data as per CRD guidance for systematic
reviews [38]. Any discrepancies in extracted data will be
discussed by two authors, and if consensus is not reached,
a third party will be consulted. In case of incomplete data,
authors will be contacted for clarification.
Assessment of risk of biases and methodological
quality Methodological rigour can vary from study to
study and certain flaws in design or study conduct cant studies and interpretations to be used in this review
Interpretations for this review
en a
likely
*For strength of association we will use odds ratio
which will be graded as 1, 2, 3, 4 with 4 being strong
association, 3 being moderate, 2 being weak
association and 1 protective [46]
rved
ferent
Findings of associations between psychological
factors and symptom exacerbation have been
established in other populations
uces a This is not going to be evaluated because single
exposure to psychological factors and outcome
of symptom relapse does not preclude a causal
relationship
Analyses will be restricted to prospective cohort
studies, a design that ensures exposure will precede
outcome
associated
sponse)
Changes in disease (symptom) activity should
correspond to changes in exposure (length or
intensity of exposure to psychological factors
or degree of stress experienced)
echanism Exposure selected in this review meets the criteria
for plausibility of scientific credible mechanism for
causality [15,17]
e current
iology of
Current evidence needs to support an association
between psychological factors and symptom relapse
alter the There are experimental studies supporting the
plausibility of causal relationship between psychological
factors and symptom exacerbation [47]
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conclusion of a study. This is particularly important for
observational studies as they are often seen as at greater
risk for bias.
The first step of assessing any potential bias within
the eligible studies is by evaluating their methodological
quality. For such evaluation the Critical Appraisal Skills
Programme (CASP) tool for cohort studies will be used
[42]. The CASP tool uses a systematic approach to ap-
praise three broad areas for consideration: study validity,
an evaluation of methodological quality and presentation
of results and an assessment of external validity [42].
There are 12 specific questions in total assessing the fol-
lowing: study validity, risk of bias in recruitment, exposure,
outcome measurement, confounding factors, reporting of
results and the transferability of findings. Each of the ques-
tions can be answered with ‘yes’, ‘no’ or ‘can’t tell’ and each
study can have a maximum score of 12.
Two reviewers will independently use the CASP tool
for cohort studies and record each quality assessment.
The scores will be used to grade the methodological
quality of each study assessed. Discussion of unresolved
disagreements regarding quality assessment with a third
person will further ensure methodological rigour.Data presentation As per CRD [38], summary of
extracted data from included studies will be presented in
tabular form as part of the review.Data synthesis, subgroup analysis and investigation
of heterogeneity We will combine data in groups by
psychological factor (minor stressors, major life events
and personality) with each containing three subgroups
for UC, CD and mixed sample of IBD in order to address
each of the aims of the systematic review (see Table 3).
We will then apply the Bradford Hill criteria for causal re-
lationship [36].
The Bradford Hill criteria are widely used to evaluate
systematically whether a causal link between an expos-
ure of interest and a health outcome exists. These cri-
teria are often used by epidemiologists to test a causal
hypothesis [43-45]. Table 4 is summarising the Bradford
hill criteria for assessing causation in cohort studies to-
gether with interpretations of each criterion that will be
used in this review. In addition to the Bradford Hill ana-
lysis, we will consider performing meta-analysis if appro-
priate. As recommended by CRD [38] and if studies
characteristics are homogeneous enough, we will group
studies and perform meta-analysis of the pooled data.
All meta-analyses would be performed using subgroup
analysis by type of disease and by type of psychological
factors.Discussion
There is still a debate and controversy about the influ-
ence of psychological factors in symptomology in IBD.
In times when the prevalence of IBD is increasing world-
wide [3,48] it is important to tackle this issue. Symptom
relapse in IBD patients is often associated with worsen-
ing of quality of life [29,49]. Thus, it is important that
service providers and IBD clinicians are provided with
clear evidence about the relationship between psycho-
logical factors and symptom exacerbation in order to de-
velop and implement appropriate therapies and services.
Consequently, new therapies may help improve the qual-
ity of life for IBD patients by reducing factors that cause
symptom exacerbation.
Systematic review status
The systematic review is currently in the phase of
screening and selection of studies. We expect comple-
tion by December 2013. PROSPERO registration number:
CRD42012003143.
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